Slide 1: Financial Results for the Six Months ended June 30, FY2026
Financial Results for the Six Months ended June 30, FY2026 August 4, 2026 ©AGC Inc. 1
Slide 2: Contents
Contents Financial Results for the Six p. 4 Months ended June 30, FY2026 1. Highlights of the Financial Results p. 5 2. Status of Segments p. 12 Outlook for FY2026 p. 19 Progress on the Growth Strategy p. 30 Appendix p. 41 ©AGC Inc. 2
Slide 3: Key Points of 2Q FY2026 Results (cumulative) and FY2026 Outlook
Key Points of 2Q FY2026 Results (cumulative) and FY2026 Outlook Financial Results for 2Q FY2026 (cumulative) ◼ Year-on-year, net sales increased by 105.1 billion JPY and operating profit rose by 10.6 billion JPY. ⚫ Net sales increased due to a favorable effect from foreign exchange, increased shipme
Slide 4: Financial Results for the Six Months ended June 30, FY2026
Financial Results for the Six Months ended June 30, FY2026 ©AGC Inc. 4
Slide 5: 1. Highlights of the Financial Results
1. Highlights of the Financial Results ©AGC Inc. 5
Slide 6: Highlights of the Financial Results for 2Q FY2026 (cumulative)
Highlights of the Financial Results for 2Q FY2026 (cumulative) （100 million JPY） Main factors in the change FY2025 FY2026 Net sales increase factors Change 1-2Q Total 1-2Q Total ◼ Impact of yen depreciation ◼ Higher shipments in Essential Chemicals in Southeast Asia, Integrated Chemicals and Electro
Slide 7: YoY Performance Comparison by Business Segment
YoY Performance Comparison by Business Segment (100 million JPY) FY2025 FY2026 Change 1-2Q Total 1-2Q Total (a) (b) (b)-(a) Net sales Operating profit Net sales Operating profit Net sales Operating profit Architectural Glass 2,108 32 2,293 88 + 185 + 55 Automotive 2,557 151 2,803 133 + 246 - 18 Elec
Slide 8: Variance Analysis on OP (1-2Q FY2026 vs 1-2Q FY2025)
Variance Analysis on OP (1-2Q FY2026 vs 1-2Q FY2025) 10.6 billion JPY up from last year （100 million JPY） ©AGC Inc. 8
Slide 9: Consolidated Statement of Financial Position
Consolidated Statement of Financial Position (100 million JPY) 2025/12/31 2026/6/30 Change Cash and cash equivalents 947 876 - 71 Inventories 4,654 4,959 + 304 Property, plant Property, plant and equipment, and equipment, 17,604 17,662 + 58 Goodwill Goodwill and and Intangible Intangible assets asse
Slide 10: Consolidated Statement of Cash Flow
Consolidated Statement of Cash Flow (100 million JPY) FY2025 FY2026 1-2Q Total 1-2Q Total Profit before tax 338 603 Depreciation and amortization 882 978 Increase(decrease) in working capital 26 - 402 Others - 74 - 131 Cash flows from operating activities 1,171 1,049 Cash flows from investing activi
Slide 11: CAPEX, Depreciation and R&D
CAPEX, Depreciation and R&D (100 million JPY) FY2025 FY2026 FY2025 FY2026 FY2025 FY2026 1-2Q Total 1-2Q Total 1-2Q Total 1-2Q Total 1-2Q Total 1-2Q Total CAPEX 969 901 Depreciation 882 978 R&D 285 288 Architectural Architectural Architectural Glass Glass 139 156 Architectural Glass Glass 127 144 Aut
Slide 12: 2. Status of Segments
2. Status of Segments ©AGC Inc. 12
Slide 13: Architectural Glass Segment
Architectural Glass Segment FY2025 FY2026 Change Variance Analysis on OP 1-2Q Total 1-2Q Total Net sales 2,108 2,293 + 185 * （100 million JPY） Asia 707 712 +5 Europe & Americas 1,387 1,574 + 186 (Inter-segment) 14 8 -6 Operating profit 32 88 + 55 * FOREX impact: +211, (100 million JPY) Change in the
Slide 14: Automotive Segment
Automotive Segment FY2025 FY2026 Change Variance Analysis on OP 1-2Q Total 1-2Q Total Net sales 2,557 2,803 + 246 * （100 million JPY） Automotive 2,556 2,802 + 246 (Inter-segment) 1 1 -0 Operating profit 151 133 - 18 * FOREX impact: +185, (100 million JPY) Change in the Scope of Consolidation: No imp
Slide 15: Electronics Segment
Electronics Segment FY2025 FY2026 Change Variance Analysis on OP 1-2Q Total 1-2Q Total Net sales 1,681 1,744 + 62 * （100 million JPY） Display 901 900 -0 Electronic Materials 772 831 + 59 (Inter-segment) 9 12 +3 Operating profit 244 187 - 57 * FOREX impact: +32, (100 million JPY) Change in the Scope
Slide 16: Chemicals Segment
Chemicals Segment FY2025 FY2026 Change Variance Analysis on OP 1-2Q Total 1-2Q Total Net sales 2,859 3,320 + 462 * （100 million JPY） Integrated Chemicals 1,458 1,656 + 198 Essential Chemicals - SEA 1,379 1,656 + 277 (Inter-segment) 22 8 - 14 Operating profit 225 282 + 56 * FOREX impact: +185, (100 m
Slide 17: Life Science Segment
Life Science Segment FY2025 FY2026 Change Variance Analysis on OP 1-2Q Total 1-2Q Total Net sales 635 723 + 88 * （100 million JPY） Life Science 617 712 + 95 0 (Inter-segment) 18 11 -7 Operating profit -119 -61 + 59 * FOREX impact: +63, (100 million JPY) Change in the Scope of Consolidation: No impac
Slide 18: Performance Contribution of Strategic Businesses
Performance Contribution of Strategic Businesses ◼ Overall net sales and operating profit improved YoY with increased sales in all strategic businesses. ◼ Improvement in operating profit was driven by Performance Chemicals growth and Life Science improvement. Main products & businesses Performance T
Slide 19: Outlook for FY2026
Outlook for FY2026 ©AGC Inc. 19
Slide 20: Impact of Middle East Developments
Impact of Middle East Developments ◼ 2Q： Maintained stable supply by securing the necessary fuels and raw materials with diversified procurement sources. Implemented price adjustments to offset rising costs of crude oil, natural gas and other raw materials. ◼ From 3Q onward： The impact on full-year
Slide 21: Essential Chemicals – SEA Update
Essential Chemicals – SEA Update ◼ The facilities in Thailand, expanded to Southeast Asia Caustic Soda and PVC Market meet steadily growing demand in Southeast Asia, began full-scale Caustic Soda PVC spread operations in 2026. ◼ Impact from the Middle East situation ⚫ Raw materials supplies were sec
Slide 22: Outlook for FY2026
Outlook for FY2026 ◼ No change to the full-year outlook. (100 million JPY) FY2025 FY2026e Net sales 20,588 22,000 （First half） 9,955 11,066 Operating profit 1,275 1,500 （First half） 540 647 Profit before tax 1,248 1,240 Profit for the year attributable to owners of the parent 692 770 Dividend (JPY/s
Slide 23: Outlook Breakdown by Segment (Net Sales and Operating Profit)
Outlook Breakdown by Segment (Net Sales and Operating Profit) ◼ No change to the full-year outlook by segment. (100 million JPY) FY2025 (a) FY2026e (b) Change (b)-(a) Operating Operating Operating Operating Operating Operating Net sales profit profit Net sales profit profit Net sales profit profit A
Slide 24: Outlook for FY2026 by Business Segment (1)
Outlook for FY2026 by Business Segment (1) Outlook for FY2026 Architectural Glass Automotive Asia ◼ Shipments are expected to decrease due to seasonal factors. ◼ Shipments are expected to increase due to seasonal factors. In Japan, renovation demand for energy-saving glass is expected ◼ Continue pro
Slide 25: Outlook for FY2026 by Business Segment (2)
Outlook for FY2026 by Business Segment (2) Outlook for FY2026 Electronics Chemicals Display Integrated Chemicals ◼ Shipments of LCD glass substrates are expected to ◼ Higher shipments of products for electronics decrease slightly. application. ◼ Continue earnings improvement measures. Electronic Mat
Slide 26: Outlook for FY2026 by Business Segment (3)
Outlook for FY2026 by Business Segment (3) Outlook for FY2026 Life Science ◼ Net sales of Small Molecule Pharmaceuticals and Agrochemicals CDMO are expected to increase, which is partly driven by launch of an expanded facility. ◼ Biopharmaceuticals CDMO are expected to increase sales and improve pro
Slide 27: Sales and Operating Profit Outlook of Strategic Businesses
Sales and Operating Profit Outlook of Strategic Businesses ◼ No change from the outlook announced in February 2026. Performance Trend of Strategic Businesses (100 Million JPY) Mobility Shipments are expected to increase. Operating profit Shipments of semiconductor-related Electronics materials inclu
Slide 28: Outlook of CAPEX, Depreciation and R&D
Outlook of CAPEX, Depreciation and R&D (From materials released in February 2026) ◼ Large-scale capacity expansions were completed by 2025, reducing CAPEX in 2026. (100 million JPY) FY2025 FY2026e FY2025 FY2026e FY2025 FY2026e CAPEX 2,513 1,900 Depreciation 1,798 1,830 R&D 603 620 Architectural Arch
Slide 29: Shareholder Return Policy
Shareholder Return Policy (From materials released in February 2026) ◼ Stable dividend with a target DOE* of approx. 3% ◼ The dividend per share for 2026 will be maintained at the 2025 level. ◼ From 2027, we will consider reviewing our shareholder returns policy in line with business recovery. Divid
Slide 30: Progress on the Growth Strategy
Progress on the Growth Strategy August 4, 2026 ©AGC Inc. 30
Slide 31: Direction of the Business Portfolio Transformation
Direction of the Business Portfolio Transformation ◼ Since 2016, we have been transforming our portfolio through the growth of Strategic Businesses. ⚫ Life Science: Focusing on stable production and contract order expansion in biopharmaceutical CDMO (Mammalian cell). ⚫ Electronics and Performance Ch
Slide 32: Status of ROCE by Business
Status of ROCE by Business ◼ Electronics and Integrated Chemicals continues to grow. ◼ Automotive, Architectural Glass, and Display are moving from recovery phase to resilience phase. ◼ Essential Chemicals - SEA and Life Science continue efforts to recover. FY2025 ROCE*¹ and Size of Capital Employed
Slide 33: Product lineup by semiconductor manufacturing process
Product lineup by semiconductor manufacturing process Growth ◼ We provide diverse products for semiconductor manufacturing, achieving a high market share. ◼ Going forward, we will also focus on packaging materials, a growth area. Semiconductor-related Products Electronics Performance Chemicals Wafer
Slide 34: Semiconductor-Related Investments (Electronics)
Semiconductor-Related Investments (Electronics) Growth ◼ Timely capacity expansion investments are made to meet growing demand for materials used in advanced semiconductors for AI and data centers. EUV Lens 20–50% Capacity Expansion CMP materials for Mask lithography to be made Slurry Blanks equipme
Slide 35: Semiconductor-Related Businesses Sales Trend
Semiconductor-Related Businesses Sales Trend Growth ◼ Aim to double our 2025 revenues by 2030, leveraging AGC’s full capabilities. ◼ Existing products will continue to drive growth. ◼ Focus as well on development and launch of new products, including packaging materials. Semiconductor-related busine
Slide 36: Earnings Improvement: Automotive and Display
Automotive and display Transitioning from Recovery to Resilience Automotive Display Maintain ROCE above 10% and drive further Target ROCE of 10% despite yen depreciation improvement. impact ROCE ROCE 10% 10% Pricing policy Structural Reform Earnings Improvement Earnings Improvement 1 Continued pursu
Slide 37: Essential Chemicals - SEA
Essential Chemicals - SEA Recovering ◼ Stable long-term earnings base supported by strong Southeast Asian demand ◼ Improving profitability by leveraging stable supply capabilities and a strong logistics network Caustic Soda and PVC Demand in Southeast Asia* Strategy Caustic soda demand PVC demand Ca
Slide 38: Life Science Recovering
Life Science Recovering ◼ Maintaining firm performance and quality for microbial, cell and gene therapy and small molecule pharmaceuticals and agrochemicals ◼ As for mammalian, cost reduction and production stabilization progressing as planned ◼ Targeting a return to profitability in 2027, continuin
Slide 39: Life Science AGC Biologics Yokohama Site
Life Science AGC Biologics Yokohama Site Recovering ◼ Construction of the AGC Biologics Yokohama Site is progressing on schedule ◼ GMP*-compliant services scheduled to start in 2027 ◼ A long-term manufacturing agreement signed with a leading global biopharmaceutical company ◼ Chosen as a strategic p
Slide 40: ROCE Improvement Measures
ROCE Improvement Measures ◼ Targeting Group-wide ROCE of 10% (equivalent to ROE of 8%) through profit improvement and optimization of operating assets across all businesses Measures to Improve Operating Optimization of Operating Assets Profit Cost Reduction Disciplined Capital Timely capacity (Stabl
Slide 41: Appendix
AGC Your Dreams, Our Challenge ©AGC Inc.
Slide 42: Sensitivity to FOREX / Market Impacts
Sensitivity to FOREX / Market Impacts (From materials released in February 2026) Impact on Operating Profit Exchange Crude Chemicals rate oil market 1 Caustic soda 500 million JPY* gain 260 million JPY* loss $1.3 million gain if the if per barrel price increased International market risen by $1 if y
Slide 43: Assumptions for Major Economies and Markets in 2026
Assumptions for Major Economies and Markets in 2026 (From materials released in February 2026, impact of Middle East Developments excluded) ◼ While some markets continue to face challenging conditions, the global economy is growing at a moderate pace Economies and Markets Assumptions for 2026 Busine
Slide 44: Variance Analysis on OP (2Q FY2026 vs 1Q FY2026)
Variance Analysis on OP (2Q FY2026 vs 1Q FY2026) 12.3 billion JPY down from last quarter （100 million JPY） ©AGC Inc. 44
Slide 45: YoY Performance Comparison by Regional Segments
YoY Performance Comparison by Regional Segments (100 million JPY) FY2025 FY2026 Change 1-2Q Total 1-2Q Total Net sales 9,955 11,006 + 1,051 FOREX impact Japan & Asia 6,241 6,789 + 549 +679 Americas 1,193 1,305 + 112 Change in the scope Europe 2,521 2,912 + 391 of consolidation Operating profit 540 6
Slide 46: YoY Net Sales Comparison by Regional Segment
YoY Net Sales Comparison by Regional Segment (100 million JPY) Japan& Asia Americas Europe Inter-segment Total 2Q FY2026 367 79 722 5 1,173 Architectural Glass 2Q FY2025 361 70 632 4 1,068 2Q FY2026 665 319 441 0 1,426 Automotive 2Q FY2025 623 281 364 0 1,269 2Q FY2026 720 111 3 7 841 Electronics 2Q
Slide 47: YoY Net Sales Comparison by Regional Segment (cumulative)
YoY Net Sales Comparison by Regional Segment (cumulative) (100 million JPY) Japan& Asia Americas Europe Inter-segment Total 1-2Q FY2026 712 145 1,429 8 2,293 Architectural Glass 1-2Q FY2025 707 144 1,243 14 2,108 1-2Q FY2026 1,329 622 851 1 2,803 Automotive 1-2Q FY2025 1,270 559 726 1 2,557 1-2Q FY2
Slide 48: Performance by Business Segment (1)
Performance by Business Segment (1) （100 million JPY） Architectural Glass 1Q FY2025 2Q FY2025 3Q FY2025 4Q FY2025 1Q FY2026 2Q FY2026 Net sales 1,040 1,068 1,100 1,203 1,120 1,173 Asia 346 361 390 438 345 367 Europe & Americas 685 703 705 761 773 801 (Inter-Segment) 10 4 5 4 2 5 Operating profit -9
Slide 49: Performance by Business Segment (2)
Performance by Business Segment (2) （100 million JPY） Chemicals 1Q FY2025 2Q FY2025 3Q FY2025 4Q FY2025 1Q FY2026 2Q FY2026 Net sales 1,441 1,417 1,455 1,529 1,572 1,748 Integrated Chemicals 717 741 750 812 784 872 Essential Chemicals - SEA 712 666 695 701 784 872 (Inter-Segment) 12 10 9 16 4 4 Oper
Slide 50: Progress of performance by segment
Progress of performance by segment (100 million JPY) FY2026 FY2026e (b) Progress (a)/(b) 1-2Q Total (a) Net sales Operating profit Net sales Operating profit Net sales Operating profit Architectural Glass 2,293 88 4,800 200 48% 44% Automotive 2,803 133 5,100 320 55% 42% Electronics 1,744 187 3,600 4
Slide 51: Market Trend
Market Trend Trend of shipment and price 2025 2026 1Q 2Q 3Q 4Q 1Q 2Q YoY comparision Architectural Japan & Asia shipment -mid single-digit -mid single-digit flat +low 10% range +low 10% range +high single-digit （AGC） price -mid single-digit -high single-digit -mid 10% range -low 10% range -low 10% r
Slide 52: ROCE and EBITDA by Business Segment
ROCE and EBITDA by Business Segment （100 million JPY） Operating profit EBITDA* ROCE Operating assets FY2024 FY2025 FY2024 FY2025 FY2024 FY2025 FY2024 FY2025 Architectural Glass 164 173 413 435 5.5% 5.2% 3,000 3,300 Automotive 139 293 464 611 4.2% 8.5% 3,350 3,450 Electronics 545 475 1,076 971 9.2% 8
Slide 53: Financial Index
Financial Index IFRS 21/12 22/12 23/12 24/12 25/12 Net sales Million JPY 1,697,383 2,035,874 2,019,254 2,067,603 2,058,832 Operating profit Million JPY 206,168 183,942 128,779 125,835 127,465 OP margin % 12.1 9.0 6.4 6.1 6.2 Profit for the year attributable to owners of the Million JPY 123,840 ▲ 3,1
Slide 54: Disclaimer
Disclaimer: ◼ This material is solely for information purposes and should not be construed as a solicitation. Although this material (including the financial projections) has been prepared using information we currently believe reliable, AGC Inc. does not take responsibility for any errors and omiss